Regulatory T cells control autoimmunity following syngeneic bone marrow transplantation

European Journal of Immunology

Volumn 36, Issue 9, 2006, Pages 2324-2335

  Bérnard, Angèle ^a   Ceredig, Rhodri ^b   Rolink, Antonius G ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Autoimmunity; Bone marrow chimeras; Regulatory T cells

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RAG2 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; BODY WEIGHT DISORDER; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DIARRHEA; ENTERITIS; FEMALE; FREQUENCY ANALYSIS; GENE DELETION; GRAFT VERSUS HOST REACTION; IMMUNOCOMPETENCE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFER; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; T CELL DEPLETION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 33748880792     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636434     Document Type: Article

References (43)

1. Nakase, K., Hara, M., Kozuka, T., Tanimoto, K. and Nawa, Y., Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant. 2006. 37, 41-44.
2. van Bekkum, D. W., Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract. Res. Clin. Haematol. 2004. 17: 201-222.
3. Adams, K. M., Holmberg, L. A., Leisenring, W., Fefer, A., Guthrie, K. A., Tylee, T. S., McDonald, G. B. et al., Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood 2004. 104: 1894-1897.
4. Latif, T., Pohlman B., Kalaycio, M., Sobecks, R., Hsi, E. D., Andresen, S. and Bolwell, B. J., Syngeneic graft-versus-host disease: a report of two cases and literature review. Bone Marrow Transplant. 2003. 32: 535-539.
5. Spaner, D., Lowsky, R., Fyles, G., Lipton, J. H., Banerjee, D., Ng, C. M., Wade, J. A. and Messner, H. A., Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient. Transplantation 1998. 66: 1251-1253.
6. Lyons, R., Narain, S., Nichols, C., Satoh, M. and Reeves, W. H., Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann. N. Y. Acad. Sci. 2005. 1050: 217-228.
7. Kronenberg, M. and Rudensky, A., Regulation of immunity by self-reactive T cells. Nature 2005. 435: 598-604.
8. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
9. Shevach, E. M., Regulatory/suppressor T cells in health and disease. Arthritis Rheum. 2004. 5O: 2721-2724.
10. Sakaguchi, S., Takahashi, T. and Nishizzuka, Y., Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. 1982. 156: 1565-1576.
11. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. and Rudensky, A. Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005. 6: 1142-1151.
12. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T Cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
13. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L, Fari, A. G. and Rudensky, A. Y., Regulatory Tcell lineage specification by the forkhead transcription factor foxp3. Immunity 2005. 22: 329-341.
14. Bosco, N., Hung, H. C., Pasqual, N., Jouvin-Marche, E., Marche, P. N., Gascoigne, N. R. and Ceredig, R., Role of the T cell receptor alpha chain in the development and phenotype of naturally arising CD4(+)CD25(+) T cells. Mol. Immunol. 2006. 43: 246-254.
15. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A. and Rudensky, A., Homeostasis and anergy of CD4(+) CD25(+) suppressor T cells in vivo. Nat. ImmunoL 2002. 3: 33-41.
16. - counterparts. J. Immunol. 2004. 172: 6123-6128.
17. + T cell receptors. Immunity 2004. 21: 267-277.
18. Azzam, H. S., DeJarnette, J. B., Huang, K., Emmons, R., Park, C. S., Sommers, C. L., El-Khoury, D. et al., Fine tuning of TCR signaling by CD5. J. Immunol. 2001. 166: 5464-5472.
19. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
20. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S., Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 1996. 184: 387-396.
21. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-S62.
22. Dolnikov, A., Shen, S., Passioura, T. and Symonds, G., Bone marrow reconstitution as a relevant model of genetically programmed leukemia. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2003. 1: 83-97
23. + regulatory T cells in tumor immunity. Curr. Top. Microbiol. Immunol. 2005. 293: 287-302.
24. + regulatory T cells. Immunol. Lett. 2005. 97: 189-192.
25. + cells in vivo. J. Immunol. 2004. 172: 3391-3398.
26. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 2003. 198: 259-266.
27. Dannull J., Su, Z., Rizzieri, D., Yang, B. K., Coleman, D., Yancey, D., Zhang, A. et al., Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 2005. 115: 3623-3633.
28. + T regulatory cells. J. Immunol. 2006. 176: 3301-3305.
29. Van Bekkum, D. W., Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003. 32 Suppl 1: S37-39.
30. - hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur. J. Immunol. 2005. 35: 2019-2030.
31. Ceredig, R. and MacDonald, H. R., Phenotypic and functional properties of murine thymocytes. II. Quantitation of host- and donor-derived cytolytic T lymphocyte precursors in regenerating radiation bone marrow chimeras. J. Immunol. 1982. 128: 614-620.
32. Lowenthal, J. W. and Harris, A. W., Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation. J. Immunol. 1985. 135: 1119-1125.
33. + T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 2004. 104: 1565-1573.
34. Nocentini G., Giunchi L., Ronchetti, S., Krausz, L. T., Bartoli, A., Moraca, R., Migliorati, G. and Riccardi, C., A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 1997. 94: 6216-6221.
35. + Regulatory T cells are spared, from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. J. Immunol. 2006. 176: 4125-4132.
36. Contractor, N. V., Bassiri H., Reya, T., Park, A. Y., Baumgart, D. C., Wasik, M. A., Emerson, S. G. and Carding, S. R., Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J. Immunol. 1998. 160: 385-394.
37. Mahler, M. and Leiter, E. H., Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm. Bowel Dis. 2002. 8: 347-355.
38. Madsen, K. L., Doyle, J. S., Tavernini, M. M., Jewell L.D., Rennie, R. P. and Fedorak, R. N., Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000. 118: 1094-1105.
39. Panwala, C. M., Jones, J. C. and Viney, J. L., A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol. 1998. 161: 5733-5744.
40. Malissen, M., Gillet, A., Ardouin, L., Bouvier, G., Trucy, J., Ferrier, P., Vivier, E. and Malissen, B., Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J. 1995. 14: 4641-4653.
41. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart V., Mendelsohn, M., Charron, J. et al., RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992. 68: 855-867.
42. Ceredig, R. and Rolink, T., A positive look at double-negative thymocytes. Nat. Rev. Immunol. 2002. 2: 888-897.
43. Harfst, E, Andersson, J., Grawunder, U., Ceredig, R. and Rolink, A. G., Homeostatic and functional analysis of mature B cells in lambda5-deficient mice. Immunol. Lett. 2005. 101: 173-184.